机构地区:[1]Department of Ophthalmology,Baylor College of Medicine,Houston,TX 77030,USA [2]School of Optometry,the Hong Kong Polytechnic University,Hong Kong,China [3]Department of Ophthalmology,Institute of Health Sciences,College of Medicine,Gyeongsang National University,Jinju52727,Korea [4]Department of Biochemistry and Molecular Biology,BaylorCollege of Medicine,Houston,TX 77030,USA
出 处:《International Journal of Ophthalmology(English edition)》2017年第9期1361-1369,共9页国际眼科杂志(英文版)
基 金:Supported by the National Institute of Health under Award Number R01 EY004446&R01 EY019908;NIH Vision Core EY02520;the Retina Research Foundation(Houston),Research to Prevent Blindness Inc.;Hong Kong Polytechnic University grants G-UA7J and G-YBQT
摘 要:AIM:To investigate the retinal toxicity and pharmacokinetics of simvastatin intravitreally injected into mice.METHODS:Forty-eight 6-8-week-old C57BL/6J mice were used in this study.Simvastatin was intravitreally injected into the right eye of each mouse;the left eye was injected with vehicle and was used as a control.Bilateral dark-adapted electroretinography(ERG)was performed 1 and 7d following injection.Histology was examined using a combination of light,fluorescence and electron microscopy.Highperformance liquid chromatography(HPLC)was used to determine the decay in the retinal simvastatin concentration.RESULTS:ERG revealed no significant changes in the simvastatin-injected eyes compared to control.Histologic studies showed normal retinal morphology in eyes injected with simvastatin up to a final vitreal concentration of 200μmol/L.No significant changes in the number of photoreceptors,bipolar cells or ganglion cells were found.The retinal simvastatin concentration decayed exponentially,with a half-life of 1.92-2.41h.CONCLUSION:Intravitreal injection of up to 200μmol/L simvastatin produced no signs of adverse effects in the mouse retina.Simvastatin reaches the retina shortly after intravitreal injectionand has a short half-life.AIM:To investigate the retinal toxicity and pharmacokinetics of simvastatin intravitreally injected into mice.METHODS:Forty-eight 6-8-week-old C57BL/6J mice were used in this study.Simvastatin was intravitreally injected into the right eye of each mouse;the left eye was injected with vehicle and was used as a control.Bilateral dark-adapted electroretinography(ERG)was performed 1 and 7d following injection.Histology was examined using a combination of light,fluorescence and electron microscopy.Highperformance liquid chromatography(HPLC)was used to determine the decay in the retinal simvastatin concentration.RESULTS:ERG revealed no significant changes in the simvastatin-injected eyes compared to control.Histologic studies showed normal retinal morphology in eyes injected with simvastatin up to a final vitreal concentration of 200μmol/L.No significant changes in the number of photoreceptors,bipolar cells or ganglion cells were found.The retinal simvastatin concentration decayed exponentially,with a half-life of 1.92-2.41h.CONCLUSION:Intravitreal injection of up to 200μmol/L simvastatin produced no signs of adverse effects in the mouse retina.Simvastatin reaches the retina shortly after intravitreal injectionand has a short half-life.
关 键 词:SIMVASTATIN RETINA ELECTRORETINOGRAPHY highperformance liquid chromatography electron microscopy intravitreal injection
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...